Skip to main content
. Author manuscript; available in PMC: 2013 May 22.
Published in final edited form as: J Am Geriatr Soc. 2010 Jan 8;58(2):292–299. doi: 10.1111/j.1532-5415.2009.02673.x

Table 2.

Percentage Change in Bone Mineral Density (BMD) in Women Aged 75 and Older with Documented Osteoporosis

BMD Test Location Relative Treatment Difference* (95% Confidence Interval) P-Value†
Femoral neck BMD
 1 year 2.3 (1.9–2.7) <.001
 3 years 5.0 (4.5–5.6) <.001
Total hip BMD
 1 year 3.0 (2.7–3.3) <.001
 3 years 6.3 (5.9–6.8) <.001
*

Least square mean difference of zoledronic acid versus placebo on the percentage change from baseline.

†

P-value calculated from analysis of variance model with treatment, study.